A nomogram was constructed to predict the survival probability at 1-, 3-, and 5-year by integrating RAE1 expression level and clinicopathological characteristics (N stage, gender (male or female), age, prothrombin time (PT), AFP level, tumor status, and pathologic stage) (Fig. 5C). This evidence concerns the gene RAE1 and neoplasm.